PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

NCT06511037 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer
Peritoneal Carcinomatosis

Interventions

DRUG: Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging

Sponsor

University of California, Irvine

Collaborators

[object Object]